Literature DB >> 1276538

The relationship between cardiotoxicity and plasma digoxin concentration in conscious dogs.

D J Chapple, R Hughes, B F Johnson.   

Abstract

1 The tendency of a given oral dose of digoxin to induce cardiac dysrhythmia was determined indirectly at various times after its administration to eight conscious dogs by measurement of the intravenous dose of acetylstrophanthidin necessary to induce toxic changes in the ECG. Acetyl-strophanthidin was used because its rapid elimination from the body permitted estimates to be made 45, 180 and 360 min after digoxin administration. 2 Each dog underwent four studies in which doses of 0.05, 0.1, 0.2 and 0.4 mg/kg digoxin were used in a randomized sequence allowing at least ten days between each dose. 3 Digoxin reduced the amount of acetylstrophanthidin required to cause toxic changes in the ECG; this increase in cardiac sensitivity was dose-dependent. 4 There was no correlation between plasma levels of digoxin and the tendency to dysrhythmia, since peak plasma concentrations of digoxin were reached at about 60 min after dosing whereas maximal sensitivity to acetylstrophanthidin was found 3 to 6 h after administration of digoxin. 5 These results suggest that there is little or no increased risk of cardiotoxicity during periods of transient increase in plasma levels of digoxin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276538      PMCID: PMC1667024          DOI: 10.1111/j.1476-5381.1976.tb07652.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

Review 1.  The kinetic behaviour of cardiac glycosides in vivo, measured by isotope techniques.

Authors:  H Lüllmann; P A van Zwieten
Journal:  J Pharm Pharmacol       Date:  1969-01       Impact factor: 3.765

2.  Correlation of the electrical and mechanical changes in the dog heart during progressive digitalization.

Authors:  M Klein; N S Nejad; B Lown; F Hagemeijer; I Barr
Journal:  Circ Res       Date:  1971-12       Impact factor: 17.367

3.  Effect of chronic circulatory volume overload on digitalis intoxication.

Authors:  G D Cope; B E Hopkins; R R Taylor
Journal:  Cardiovasc Res       Date:  1973-09       Impact factor: 10.787

4.  Editorial: Digoxin--the regulatory viewpoint.

Authors:  J G Harter; J P Skelly; A W Steers
Journal:  Circulation       Date:  1974-03       Impact factor: 29.690

5.  Non-equivalence of digoxin tablets.

Authors:  P Reissell; V Manninen; K Ojala; J Karjalainen
Journal:  Ann Clin Res       Date:  1974

6.  Plasma concentration and urinary excretion kinetics of acetyl strophanthidin.

Authors:  R Selden; M D Klein; T W Smith
Journal:  Circulation       Date:  1973-04       Impact factor: 29.690

7.  Effects of acetyl strophanthidin on cardiovascular function in intact, conscious dogs.

Authors:  R Kumar; W B Hood; D P Gilmour; W H Abelmann
Journal:  J Pharmacol Exp Ther       Date:  1972-01       Impact factor: 4.030

8.  Correlation of the electrophysiologic action of digoxin with serum digoxin concentration.

Authors:  I Barr; T W Smith; M D Klein; F Hagemeijer; B Lown
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030

9.  Biological availability of digoxin from Lanoxin produced in the United Kingdom.

Authors:  B F Johnson; A S Fowle; S Lader; J Fox; A D Munro-Faure
Journal:  Br Med J       Date:  1973-11-10

10.  Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.

Authors:  D Falch; A Teien; C J Bjerkelund
Journal:  Br Med J       Date:  1973-03-24
View more
  5 in total

1.  Prediction of digoxin dose requirements.

Authors:  S M Dobbs; G E Mawer
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 2.  Pharmacokinetic interactions with digoxin.

Authors:  S M Rodin; B F Johnson
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

3.  Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib.

Authors:  Jules I Schwartz; Nancy G B Agrawal; Martin Wehling; Bret J Musser; Carol P Gumbs; Nicole Michiels; Marina De Smet; John A Wagner
Journal:  Br J Clin Pharmacol       Date:  2008-09-24       Impact factor: 4.335

4.  Transient changes in plasma digoxin concentration and the development of cardiotoxicity.

Authors:  D J Chapple; R Hughes; B F Johnson
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

5.  Arrhythmogenic dose of acetylstrophanthidin unchanged by beta-sympathomimetics in conscious dogs.

Authors:  M Haass; G Sponer; U Abshagen
Journal:  Basic Res Cardiol       Date:  1984 Nov-Dec       Impact factor: 17.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.